New York State Common Retirement Fund
KLDO

New York State Common Retirement Fund’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

New York State Common Retirement Fund’s Portfolio KLDO Stock Details KLDO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9,073
Closed -$15K – 3623
2022
Q1 		$15K Sell
9,073
-10
-0.1% -$18 ﹤0.01% 3303
2021
Q4 		$22K Hold
9,083
– – ﹤0.01% 3293
2021
Q3 		$50K Buy
9,083
+79
+0.9% +$490 ﹤0.01% 3243
2021
Q2 		$67K Buy
9,004
+104
+1% +$737 ﹤0.01% 3249
2021
Q1 		$72K Hold
8,900
– – ﹤0.01% 3148
2020
Q4 		$81K Hold
8,900
– – ﹤0.01% 3104
2020
Q3 		$99K Hold
8,900
– – ﹤0.01% 2927
2020
Q2 		$66K Hold
8,900
– – ﹤0.01% 3117
2020
Q1 		$55K Hold
8,900
– – ﹤0.01% 2962
2019
Q4 		$45K Hold
8,900
– – ﹤0.01% 3139
2019
Q3 		$67K Hold
8,900
– – ﹤0.01% 3120
2019
Q2 		$103K Buy
+8,900
New +$130K ﹤0.01% 3093

Other funds holding KLDO

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

New York State Common Retirement Fund's KLDO Position: Q2 2022 in Review

New York State Common Retirement Fund sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q2 2022, closing a stake of 9,073 shares — an estimated $15K sold.

New York State Common Retirement Fund first reported a position in KLDO in Q2 2019 and held it in 12 quarters. The position peaked at $103K in Q2 2019. 3 funds tracked by Wall St. Rank hold KLDO as of Q2 2022.

  • New York State Common Retirement Fund reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • New York State Common Retirement Fund sold 9,073 Kaleido Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $15K.
  • New York State Common Retirement Fund first reported a position in Kaleido Biosciences, Inc. Common Stock in Q2 2019 and held it in 12 quarters.
  • New York State Common Retirement Fund's Kaleido Biosciences, Inc. Common Stock position peaked at $103K in Q2 2019.
  • 3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q2 2022.

Based on New York State Common Retirement Fund's 13F filing for Q2 2022, filed 4 Aug 2022.